NEC‐related deaths during study period · preventing necrotizing enterocolitis in preterm and low birth weight neonates
It is very uncertain whether summary of findings table for oral immunoglobulin changes NEC‐related deaths during study period compared with control (very low certainty).
1 finding from 1 review
Weight (g) at 4 months · preterm or low birth weight infants undergoing hospital care
1 finding from 1 review
Length of stay (days) (CL from 32 weeks' PMA) · preterm or low birth weight infants undergoing hospital care
1 finding from 1 review
Preterm labour · women with a twin pregnancy
Oral betamimetic may leads to lower preterm labour compared with placebo (low certainty).
1 finding from 1 review
Incidence of RDS frequency in newborns · women at risk of preterm birth
Ambroxol showed no clear difference in incidence of RDS frequency in newborns compared with corticosteroid (betamethasone) (moderate certainty).
1 finding from 1 review
Perinatal mortality frequency of deaths of newborns · women at risk of preterm birth
Ambroxol showed no clear difference in perinatal mortality frequency of deaths of newborns compared with corticosteroid (betamethasone) (moderate certainty).
1 finding from 1 review
Adverse effects in pregnant women frequency in pregnant women · women at risk of preterm birth
It is very uncertain whether ambroxol changes adverse effects in pregnant women frequency in pregnant women compared with corticosteroid (betamethasone) (very low certainty).
1 finding from 1 review
Incidence of RDS frequency in newborns · women at risk of preterm birth
Ambroxol showed no clear difference in incidence of RDS frequency in newborns compared with placebo or no treatment (low certainty).
1 finding from 1 review
Perinatal mortality frequency of deaths of newborns · women at risk of preterm birth
Ambroxol showed no clear difference in perinatal mortality frequency of deaths of newborns compared with placebo or no treatment (low certainty).
1 finding from 1 review
Adverse effects in pregnant women frequency in pregnant women · women at risk of preterm birth
Ambroxol showed no clear difference in adverse effects in pregnant women frequency in pregnant women compared with placebo or no treatment (low certainty).
1 finding from 1 review
Other events in newborns ‐ Administration of pulmonary surfactant frequency in newborns · women at risk of preterm birth
Ambroxol showed no clear difference in other events in newborns ‐ Administration of pulmonary surfactant… compared with placebo or no treatment (low certainty).
1 finding from 1 review
Other events in newborns ‐ Need for mechanical ventilation frequency inf newborns · women at risk of preterm birth
Ambroxol showed no clear difference in other events in newborns ‐ Need for mechanical ventilation frequency… compared with placebo or no treatment (low certainty).
1 finding from 1 review
Intervention not reported
Exchange transfusion · preterm or low birth weight infants
The intervention probably leads to lower exchange transfusion (moderate certainty).
1 finding from 1 review
Intervention not reported
Cerebral palsy · preterm or low birth weight infants
The intervention showed no clear difference in cerebral palsy (moderate certainty).
1 finding from 1 review
Intervention not reported
Peak serum bilirubin · preterm or low birth weight infants
1 finding from 1 review
Intervention not reported
Serum bilirubin greater than 10 mg/dl · preterm or low birth weight infants
The intervention probably leads to lower serum bilirubin greater than 10 mg/dl (moderate certainty).
1 finding from 1 review
Intervention not reported
Retinopathy of prematurity · preterm or low birth weight infants
The intervention showed no clear difference in retinopathy of prematurity (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality · preterm or low birth weight infants
The intervention showed no clear difference in all‐cause mortality (moderate certainty).
1 finding from 1 review
Days to regain birth weight · feed interruption while monitoring gastric residual
1 finding from 1 review
Intervention not reported
Necrotising enterocolitis prior to hospital discharge · very preterm (< 32 weeks' gestation) or very low birth weight (< 1500 g) infants
The intervention may leads to lower necrotising enterocolitis prior to hospital discharge (low certainty).
1 finding from 1 review